CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 139 enrolled
Drug / intervention
Standard care with a facemask. +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05524220
NCT05524220N/ACompleted
CompareCT.gov

Effect of Nasal Positive Airway Pressure Versus Standard Care on Oxygenation and Ventilation During Propofol-based Sedation for Colonoscopy in Patients With High Risk of Airway Obstruction: a Prospective Randomized Controlled Trial.

The University of Texas Health Science Center, Houston·interventional·Posted Sep 1, 2022·Updated Apr 22, 2025

In Brief

A clinical study evaluating Standard care with a facemask. and SuperNO2VA™EtCO2 (Nasal Oxygenating Ventilating Apparatus) for Obstructive Sleep Apnea, Obesity. Completed, enrolled 139 participants across 1 site.

Detailed Summary

The purpose of this study is to to compare oxygenation and ventilation on spontaneously ventilating obese patients or those with diagnosed or undiagnosed Obstructive sleep apnea (OSA) undergoing day colonoscopy under Propofol based sedation, between the SuperNO2VA Et™ nasal positive airway pressure (PAP) device and routine care with face mask for oxygen (O2).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObstructive Sleep Apnea, Obesity
CountriesUnited States
CollaboratorsVyaire Medical

Timeline

N/ACompletedFinished
2023202420252026
First PostedSep 1, 2022
Enrollment StartDec 19, 2022
Primary CompletionAug 9, 2023
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 3.8 years ago

Interventions

Standard care with a facemask.device

The anesthesia provider will supply oxygen via the closed facemask at 10 liters per minute (LPM)

SuperNO2VA™EtCO2 (Nasal Oxygenating Ventilating Apparatus)device

The anesthesia provider will attach the SuperNO2VA™ EtCO2 circuit port to the hyperinflation bag with the oxygen flow rate to 10 L/min. The oxygenation, continuous positive airway pressure, and ventilation of the subject will be done via SuperNO2VA™EtCO2 (Nasal Oxygenating Ventilating Apparatus)